Mark Schoenberg, Chief Medical Officer at UroGen Pharma Ltd. (URGN), sold 1,900 shares at $10.12 ($19K) on 2023-01-31, disclosed to the SEC on 2023-02-02.
Open-market sale of $19k URGN by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.12 | 248 | $3K | 13.1% |
| 2 | $10.12 | 661 | $7K | 34.8% |
| 3 | $10.12 | 991 | $10K | 52.2% |
| Total | $10.12 avg | 1,900 | $19K | 100% |
| Filing → |
| URGN | SELL | 2026-07-10 | $400K | — | Filing → |
| URGN | SELL | 2026-06-24 | $350K | — | Filing → |
| URGN | SELL | 2026-06-09 | $143K | — | Filing → |